- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05657665
Skin Tone Measurement Method Investigation for Pulse Oximetry
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Skin tone bias in pulse-oximetry (SpO2) needs to be addressed urgently. While skin pigmentation is a prime candidate for the root cause of skin tone bias in SpO2, more research is needed. F A solid comparison and recommendation requires evaluation of several additional aspects that affect accuracy, precision, and reproducibility of the PMMs.
Briefly, these additional aspects that are evaluated in this study are listed below:
- operator bias
- impact of operator color blindness
- probe pressure
- probe aperture size
- device stability
- impact of blood on pigmentation measurement
- feasibility of skin tone measurement on sides of fingers
- intra-operator variability
PMMs included in this study are:
Subjective color matching methods by using:
- Von Luschan color scale
- Fitzpatrick color scale
- Pantone color scale
Objective probe-based measurements by using:
- Konica Minolta CM700d (reflectance spectrometer)
- Mx18 (erythema-melanin meter)
- SPA99 (erythema-melanin meter)
Measurements will be performed on 5 relatively light skinned, and 5 relatively dark skinned volunteers (N=10 in total*). The study will be executed on the High-Tech Campus Eindhoven (Netherlands) and each participant will have 3 visits of approximately 1.5 to 2 hours/visit.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Leonie van den Heuvel
- Phone Number: 0031612318126
- Email: leonie.van.den.heuvel@philips.com
Study Contact Backup
- Name: Willem Verkruijsse
- Phone Number: 0031617418443
- Email: wim.verkruijsse@philips.com
Study Locations
-
-
-
Eindhoven, Netherlands
- High Tech Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults (18-65 years)
- Fluent in either English or Dutch
- Participants who are willing and able to provide informed consent themselves.
- People with Von Luschan scores <18 ('light skin' group) or > 25 ('dark skin' group).
Exclusion Criteria:
Skin conditions that could potentially interfere with the measurements:
- piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
- vascular or pigmentary or renal psoriasis
- epidermal bullosum
- other diseases that affect the skin (tone) of the body
COVID-19 exclusion criteria*:
- Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
- Having been positively tested as infected with COVID-19 in the past 14 days
- Travelled to or from high risk COVID-19 areas in the past 14 days
- Been in contact with a (suspected) COVID-infected person in the past 14 days
- Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
- Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
- Known allergic reaction to facial make-up
- Usage of tanning sprays/cremes
Wearing make-up during the study visits (mascara is allowed)
- No testing will be performed in the study. Participants will be asked if they have been positively tested.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preferred skin PMM in the context of pulse-oximetry.
Time Frame: 10 months
|
The primary objective is to complement a previous skin pigmentation study executed by Philips to gather missing information in order to form a well-founded recommendation on which is the preferred skin PPM in the context of pulse-oximetry.
|
10 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ICBE-S-000880
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulse Oximetry
-
GE HealthcareCompleted
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
University of MinnesotaCompleted
-
Medline IndustriesClinimark, LLCTerminated
-
University of California, San DiegoRecruitingPulse OximetryUnited States
-
University of California, San DiegoRecruitingPulse Oximetry | Generalised Melanin PigmentationUnited States
-
City, University of LondonBarts & The London NHS TrustCompleted
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; London Health Sciences Centre; Al Shifa...Active, not recruitingPulse Oximetry | Free and Open SourceCanada
-
Peking Union Medical College HospitalCompletedPulse Oximetry Plethymographic Waveform | Area Under Curve | AmplitudeChina
Clinical Trials on Observational measurements of skin tone
-
Assistance Publique - Hôpitaux de ParisCompletedLung Neoplasms | Liver Neoplasms | Arteriovenous Malformations | Aneurysm | Coronary OcclusionFrance
-
DermTechUniversity of PittsburghNot yet recruitingMelanoma and Other Malignant Neoplasms of SkinUnited States
-
University of SevilleHospital Universitario Virgen Macarena; Hospitales Universitarios Virgen del...CompletedStroke | Pain | Muscle Spasticity | Muscle Tone AbnormalitiesSpain
-
SensorionRecruitingSensorineural Hearing Loss, Bilateral | Congenital Deafness | AUNB1 | DFNB1A | DFNB9 | OTOF Gene Mutation | GJB2 Gene MutationFrance
-
Marmara UniversityRecruitingCerebral Palsy | Infant, Premature, Diseases | Preterm Birth ComplicationTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedCerebral Palsy | Infant, Premature, Diseases | Neurologic Disorder | Infant, Newborn, Disease | Infant Development | Development Delay | Infant, Very Low Birth Weight | Infant, Small for Gestational Age | Infant AsphyxiaTurkey
-
M.D. Anderson Cancer CenterTerminatedPancreatic NeoplasmsUnited States
-
Istanbul Medeniyet UniversityNot yet recruiting
-
United States Army Institute of Surgical ResearchCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed